🇺🇸 FDA
Pipeline program

Paclitaxel

NSABP FB-7

Phase 2 small_molecule completed

Quick answer

Paclitaxel for Breast Cancer is a Phase 2 program (small_molecule) at PUMA BIOTECHNOLOGY, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
PUMA BIOTECHNOLOGY, INC.
Indication
Breast Cancer
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials